These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1619520)

  • 1. Psychoactive drugs and human sexual behavior: the role of serotonergic activity.
    Meston CM; Gorzalka BB
    J Psychoactive Drugs; 1992; 24(1):1-40. PubMed ID: 1619520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic drugs and sexual behaviour.
    Barnes TR; Bamber RW; Watson JP
    Br J Hosp Med; 1979 Jun; 21(6):594-600. PubMed ID: 38874
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of serotonin and female sexual behavior.
    Uphouse L
    Pharmacol Biochem Behav; 2014 Jun; 121():31-42. PubMed ID: 24239784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V; Ahlenius S
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence.
    Paredes RG; Agmo A
    Prog Neurobiol; 2004 Jun; 73(3):179-226. PubMed ID: 15236835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
    Sellers EM; Higgins GA; Tomkins DM; Romach MK; Toneatto T
    J Clin Psychiatry; 1991 Dec; 52 Suppl():49-54. PubMed ID: 1752860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological, neurotransmitter, and pharmacological aspects of sexual behavior.
    Karczmar AG
    Psychopharmacol Bull; 1975 Jul; 11(3):39-40. PubMed ID: 239435
    [No Abstract]   [Full Text] [Related]  

  • 11. Mixing pleasures: review of the effects of drugs on sex behavior in humans and animal models.
    Frohmader KS; Pitchers KK; Balfour ME; Coolen LM
    Horm Behav; 2010 Jun; 58(1):149-62. PubMed ID: 20004662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.
    Leysen JE; Van Gompel P; Gommeren W
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain serotonin, psychoactive drugs, and effects on reproduction.
    Ayala ME
    Cent Nerv Syst Agents Med Chem; 2009 Dec; 9(4):258-76. PubMed ID: 20021359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of depression and antidepressants on sexual functioning.
    Gitlin MJ
    Bull Menninger Clin; 1995; 59(2):232-48. PubMed ID: 7795566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.
    Di Giovanni G; Di Matteo V; Esposito E
    Indian J Exp Biol; 2002 Dec; 40(12):1344-52. PubMed ID: 12974395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats.
    Meririnne E; Kajos M; Kankaanpää A; Seppälä T
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):346-50. PubMed ID: 16623856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets.
    Aubert Y; Bohl MA; Lange JR; Diol NR; Allers KA; Sommer B; Datson NA; Abbott DH
    Psychoneuroendocrinology; 2013 Jan; 38(1):145-54. PubMed ID: 22727480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
    Peroutka SJ
    Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.